|
David L. Castaldi has been a director of the Company since 1994. He is currently an independent consultant. Mr. Castaldi was founder and Chairman of the Board (1996-2001) and Chief Executive Officer (1998-1999) of Cadent Medical Corp. a medical device company that was sold to Cardiac Science Inc. Previously Mr. Castaldi was founder and Chief Executive Officer (1987-1994) of BioSurface Technology Inc. a NASDAQ-listed biotechnology company that was sold to Genzyme Corporation. He also served as President of Baxter International’s worldwide plasma fractionation division where he was the corporate sponsor for the development of recombinant Factor VIII a biopharmaceutical with sales over $1 billion. He is a graduate of the University of Notre Dame (maxima cum laude) and Harvard Business School (with high distinction) where he was a Baker Scholar. Mr. Castaldi also serves on the Boards of Embrex Inc. | 